Better effect of sorafenib on the rhabdoid component of a clear cell renal cell carcinoma owing to its higher level of vascular endothelial growth factor-A production

Histopathology

Volumn 59, Issue 3, 2011, Pages 562-564

  Kats Ugurlu, Gursah ^a   Maass, Cathy ^a   van Herpen, Carla ^a   de Waal, Rob ^a   Oosterwijk, Egbert ^a   Mulders, Peter ^a   Hulsbergen van de Kaa, Christina ^a   Leenders, William ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SORAFENIB; VASCULOTROPIN A;

ADULT; ANTIANGIOGENIC THERAPY; CANCER ADJUVANT THERAPY; CANCER SURGERY; CASE REPORT; CHEMOSENSITIVITY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY SURGERY; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RHABDOID TUMOR; TUMOR NECROSIS;

ANTINEOPLASTIC AGENTS; ARTHRITIS, RHEUMATOID; BENZENESULFONATES; CARCINOMA, RENAL CELL; CLINICAL TRIALS AS TOPIC; DEPRESSION; FEMALE; HUMANS; HYPERTENSION; KIDNEY NEOPLASMS; MIDDLE AGED; NEOADJUVANT THERAPY; PYRIDINES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80053298070     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03923.x     Document Type: Letter

References (5)

1. Gotink KJ, Verheul HMW. Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? Angiogenesis 2010; 13; 1-14.
2. Kapoor A, Tutino R, Kanaroglou A, Hotte SJ. Treatment of adult rhabdoid renal cell carcinoma with sorafenib. Can. Urol. Assoc. J. 2008; 2; 631-634.
3. Cowey CL, Amin C, Pruthi RS et al. Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma. J. Clin. Oncol. 2010; 28; 1502-1507.
4. Gokden N, Nappi O, Swanson PE et al. Renal cell carcinoma with rhabdoid features. Am. J. Surg. Pathol. 2000; 24; 1329-1338.
5. Shannon B, Wisniewski ZS, Bentel J, Cohen RJ. Adult rhabdoid renal cell carcinoma. Divergent differentiation of conventional (clear cell) carcinoma. Arch. Pathol. Lab. Med. 2002; 126; 1506-1510.